In a study using biopsy specimens of 74 patients with nonalcoholic fatty liver disease (NAFLD), the expression of all genes (including Acad1) involved in the metabolism of fatty acids and iron were significantly downregulated as the stage and grade of NAFLD progressed [23]. The gene discussed is ACADM; the disease is metabolic dysfunction-associated steatotic liver disease.